How Research Reveals Target for Prostate Cancer Treatment

Back-to-back discoveries from Cleveland Clinic demonstrate for the first time how a testosterone-related genetic abnormality can help predict individual patient responses to specific prostate cancer therapies. The studies suggest that men who inherit this variant would benefit from a personalized treatment plan that targets specific hormonal pathways.

Related Links